Hit the nail on the head. This companies success i

Hit the nail on the head. This companies success is based upon lining up the science, and partnerships that go hand in hand with the science. This takes time. I am very optimistic about the 2nd data set, and believe that the results will be good. The long term value imo is in MANF with LYMPRO being the bridge. Lympro will create a significant revenue stream, but won't be the kingpin that MANF will be if everything plays out like we think it will. I am here for years because the true value won't be realized until then.